FDA inspection
Niagara Pharmaceuticals Inc: FDA inspection ending Sep 18, 2017
FDA inspection 1031416 · No Action Indicated (NAI) · Dundas
Key facts
| Inspection ID | 1031416 |
|---|---|
| Firm | Niagara Pharmaceuticals Inc |
| FEI number | 3003093882 |
| Address | 60 Innovation Dr |
| City | Dundas |
| Country | Canada |
| Fiscal year | 2017 |
| Inspection end date | Sep 18, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data